Skip to main content

Seth Darst joins National Academy of Sciences

Seth Darst, whose research explores the mechanisms by which RNA is transcribed from DNA, has been elected to the National Academy of Sciences, one of the highest honors given to a scientist or engineer in the United States. Darst will be inducted into the Academy next April during its annual meet...

Jeffrey Ravetch elected to American Academy of Arts and Sciences

Jeffrey V. Ravetch, an immunologist who studies how cells respond to specific antibodies, has been elected to The American Academy of Arts and Sciences, an independent policy research center that undertakes studies of complex and emerging problems. The academy announced the election this week; Ra...

New policy at Rockefeller University Press allows authors to retain copyright to their published work

Citing the growing demand from the public and the scientific community for access to research data, The Rockefeller University Press has revised its copyright policy to allow authors to retain the rights to work published in its three journals. The policy, which became effective May 1, applies to...

Newly refined antibody therapy may be potent treatment for autoimmune diseases

An old, fickle therapy for a variety of autoimmune diseases is getting a makeover, thanks to a decade-long investigation by Rockefeller University researchers. The original treatment, called intravenous immunoglobulin or IVIG, is an amalgam of specific antibodies made from the pooled blood plasma...

Rockefeller University hosts two-day evolution symposium

Beginning with the molecular origins of life and culminating with the latest findings on human evolution, 18 of the world’s leading experts will report on research spanning three billion years of evolution at a two-day symposium at Rockefeller University. The symposium takes place on Thursday, Ma...

New molecule could be key to new anti-heart-attack drug

When too many blood platelets stick together in the bloodstream, they form dangerous clots that can clog blood vessels and cause a heart attack. If a clot doesn’t get dissolved or rapidly removed, it can cause permanent damage or even death. But new research by Rockefeller University scientists s...

Miles O’Brien, Susan Wood, Paul Nurse to be panelists at public ‘Science and Politics’ event

A public event on science and politics, to take place at Rockefeller University on April 29, will feature panelists from science, journalism and government discussing obstacles to reasoned debate and sound policies in science. The discussion, called “Conversations on Science and Politics,” will ...

Insects evolved a radically different strategy to smell

Darwin’s tree of life represents the path and estimates the time evolution took to get to the current diversity of life. Now, new findings suggest that this tree, an icon of evolution, may need to be redrawn. In research published in the April 13 advance online issue of Nature, researchers at Roc...

Slightly abnormal blood test may point to a 'silent' form of hepatitis B

Silence isn’t always golden. In the case of hepatitis B, people with a past — and seemingly resolved — infection often don’t know that they still have a silent form of the disorder. Now, new research suggests that slightly abnormal results from a blood test, once thought to be a fleeting cur...

Final episode of 'Charlie Rose Science Series' airs April 7

The final episode of the “Charlie Rose Science Series,” which over the past 18 months has featured shows focused on the brain, longevity, stem cells, pandemics and other science topics, will air Monday, April 7. Rockefeller University President Paul Nurse has served as cohost, with Charlie Rose...